维普中文期刊产品整合服务
13篇 您的检索式:作者名="ABENDROTH D"
    题名 作者 年代 出处 被引量
1Rapamycin rescue therapy in patients afrer kidney transplantation:first clinical experience显示文摘Weber T Abendroth D Schelzing H 0,,02:1
2Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression显示文摘Slobedman B Stern J L Cunningham A L Abendroth A Abate D A Mocarski E S 2004J Virol2004,78,8:1
3IMPDH activity in whole blood and isolated blood cell fraction for monitoring of Cellcept-mediated immunosuppression显示文摘STORCK M ABENDROTH D ALBRECHT W 1999Transplant Proc1999,31,12:1
4Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience 显示文摘Weber T Abendroth D Schelzig H 2005Transpl Int2005,18,2:1
5Diabetic microangiopathy in type Ⅰ insulin-dependent diabetic patients after successful pancreatic and kidney or solitary kidney transplantation显示文摘Abendroth D Schmand J Landgraf R 1991Diabetologia1991,341,:1
6Immunocytochemical staining of unstained versus previously stained cytologic preparations显示文摘Abendroth C S Dabbs D J 1995Acta Cytol1995,39,3:1
7Intraoperative immunocytochemistry of cytologic scrape specimens 显示文摘Dabbs D J Hafer L Abendroth C S 1995A rapid immunoperoxidase method for triage and diagnosis [J] Acta Cytol1995,39,:1
8Pretransplantassessment of renal viability by using ion-selective electrodes-apilot study显示文摘Abendroth D Schilling M Fenzlein PG 1993Transplant Proc1993,25,4:1
9Appl Phys Lett 显示文摘Grittier D Abendroth B Grfitzschel R 200485:61342004,85,:1
10IMPDH activity in whole blood and isolated blood cell fraction for monitoring of CellCept-mediated immunosuppression 显示文摘Storck M Abendroth D Albrecht W 1999Transplant Proc1999,31,12:1
11The three- dimen- sional structure of the cytoplasmic domains of EpsF from the type 2 secretion system of Vibrio cholerae显示文摘Abendroth J Mitchell D D Korotkov K V 2009Journal of Structural Biology2009,166,3:1
12The role of polysulfide-saturation in electrolytes for high power applications of real world Li-S pouch cells显示文摘The lithium-sulfur(Li-S)technology is the most promising candidate for next-generation batteries due to its high theoretical specific energy and steady progress for applications requiring lightweight batteries such as aviation or heavy electric vehicles.For these applications,however,the rate capability of Li-S cells requires significant improvement.Advanced electrolyte formulations in Li-S batteries enable new pathways for cell development and adjustment of all components.However,their rate capability at pouch cell level is often neither evaluated nor compared to state of the art(SOTA)LiTFSI/dimethoxyethane/dioxolane(LITFSI:lithium-bis(trifluoromethylsulfonyl)imide)electrolyte.Herein,the combination of the sparingly polysulfide(PS)solvating hexylmethylether/1,2-dimethoxyethane(HME/DME)electrolyte and highly conductive carbon nanotube Buckypaper(CNT-BP)with low porosity was evaluated in both coin and pouch cells and compared to dimethoxyethane/dioxolane reference electrolyte.An advanced sulfur transfer melt infiltration was employed for cathode production with CNT-BP.The Li+ion coordination in the HME/DME electrolyte was investigated by nuclear magnetic resonance(NMR)and Raman spectroscopy.Additionally,ionic conductivity and viscosity was investigated for the pristine electrolyte and a polysulfide-statured solution.Both electrolytes,DME/DOL-1/1(DOL:1,3-dioxolane)and HME/DME-8/2,are then combined with CNT-BP and transferred to multi-layered pouch cells.This study reveals that the ionic conductivity of the electrolyte increases drastically over state of(dis)charge especially for DME/DOL electrolyte and lean electrolyte regime leading to a better rate capability for the sparingly polysulfide solvating electrolyte.The evaluation in prototype cells is an important step towards bespoke adaption of Li-S batteries for practical applications.Tom Boenke Sebastian Kirchhoff Florian SReuter Florian Schmidt Christine Weller Susanne Dörfler Kai Schwedtmann Paul Härtel Thomas Abendroth Holger Althues Jan J.Weig Stefan Kaskel 2023Nano Research2023,16,6:0
13C-反应蛋白在大鼠自体静脉移植动脉化中的作用显示文摘目的探讨C-反应蛋白(CRP)在自体静脉移植动脉化中是否参与血管重塑过程。方法通过建立自体静脉移植动脉化模型,CBS3830加以干预,应用ELISA法检测CRP水平;术后1周和2周检测内膜厚度;Western blot法检测p38、P-p38表达。结果 0~2周各时间点内,模型组CRP水平呈逐渐上升趋势,假手术组呈先上升后下降趋势,两组比较差异有统计学意义(P<0.05),在1、2周时,药物组与模型组、假手术组比较差异均有统计学意义(P<0.05)。药物组内膜增生与模型组比较差异有统计学意义(P<0.01)。1周后p38、P-p38产物表达药物组明显低于模型组及假手术组(P<0.01,P<0.05)。结论 CRP参与了自体静脉移植动脉化血管重塑过程;但可能与p38MAPK通路无关,CBS3830对其没有起到明显的抑制作用。周经月 葛建军 赵智伟 邬松 Abendroth D K 2011安徽医科大学学报2011,46,12:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费